CFSAN Visiting Supplement Companies For Information On Developing GMPs
This article was originally published in The Tan Sheet
Executive Summary
FDA representatives have visited three dietary supplement manufacturing facilities the last two months and will visit three more the week of Sept. 30 to better understand the manufacturing practices of the supplement industry. The information gathered during the visits will be used as the agency develops its proposed rule for dietary supplement Good Manufacturing Practices.
You may also be interested in...
Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall
Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.
Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall
Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.
Supplement GMPs Should Proceed Despite Economic Concerns - CRN, Rexall
Concerns over the economic burden that small companies will face when implementing Good Manufacturing Practices for dietary supplements should not delay or unduly affect FDA's rulemaking, industry commenters advise.